Literature DB >> 2961377

Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophils.

M Berger1, E M Wetzler, R S Wallis.   

Abstract

Interleukin-1 (IL-1) and other monocyte products have several important effects on the systemic response to infection in addition to their roles in lymphocyte stimulation. The present studies were carried out to determine whether products of stimulated monocytes activated circulating neutrophils (PMN) to increase expression of receptors for C3b (CR1) and C3bi (CR3), which are necessary for optimal margination, migration, and phagocytosis. Supernatants of human mononuclear cells that had been stimulated with lipopolysaccharide (LPS) or purified protein derivative (PPD) contained both tumor necrosis factor (TNF) and IL-1 and increased CR1 and CR3 expression on isolated PMNs. Supernatants of unstimulated cultures, media alone, or LPS or PPD alone had little or no effect. Supernatant effects were detectable at 1:3,000 final dilution and appeared to have a characteristic slow time course. These supernatants also caused dose- and time-dependent secretion of PMN granular constituents, but maximal receptor expression was accompanied by secretion of less than 10% of the cells' content of lysozyme and less than 16% of the B12 binding protein. Immunoadsorption studies showed that the supernatant's activity could be removed by anti-TNF but not by anti-IL-1. Recombinant IL-1 had no effect on receptor expression, but recombinant TNF increased CR1 and CR3 expression with kinetics similar to the supernatants. These results thus indicate that TNF is the major monocyte product that increases CR1 and CR3 expression on mature blood neutrophils. This would result in increased margination and phagocytic activity and may be an important systemic effect that would help the host eradicate infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2961377

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  30 in total

1.  CR3-dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement-opsonized Cryptococcus neoformans.

Authors:  C E Cross; H L Collins; G J Bancroft
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

2.  Effects of tumor-necrosis-factor-activated neutrophils on tumor cell survival.

Authors:  H Shau
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Neutrophil-mediated cartilage injury in vitro is enhanced by tumour necrosis factor alpha.

Authors:  I C Kowanko; E J Bates; A Ferrante
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

4.  Protection of mice against Listeria monocytogenes infection by recombinant human tumor necrosis factor alpha.

Authors:  J V Desiderio; P A Kiener; P F Lin; G A Warr
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

5.  Disparate effects of interferon-gamma and tumor necrosis factor-alpha on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro.

Authors:  R D Diamond; C A Lyman; D R Wysong
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

6.  Pneumonia in the surgical intensive care unit. Immunologic keys to the silent epidemic.

Authors:  W Naziri; W G Cheadle; J D Pietsch; S Appel; H C Polk
Journal:  Ann Surg       Date:  1994-06       Impact factor: 12.969

7.  Identification of a highly mobilizable subset of human neutrophil intracellular vesicles that contains tetranectin and latent alkaline phosphatase.

Authors:  N Borregaard; L Christensen; O W Bejerrum; H S Birgens; I Clemmensen
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

8.  Impaired phagocyte responses to lipopolysaccharide in paroxysmal nocturnal hemoglobinuria.

Authors:  J Duchow; A Marchant; A Crusiaux; C Husson; C Alonso-Vega; D De Groote; P Neve; M Goldman
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils.

Authors:  François Niyonsaba; Hideoki Ogawa; Isao Nagaoka
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

10.  Modulation of transmembrane signalling in HL-60 granulocytes by tumour necrosis factor-alpha.

Authors:  K R McLeish; J B Klein; T Schepers; G Sonnenfeld
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.